This $737,899 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will fund the development and evaluation of a nontrauma intervention to treat post-traumatic stress disorder (PTSD) in veterans and service members suffering from traumatic brain injury (TBI). The University of Texas Health Science Center at San Antonio, a state-controlled institution of higher learning, will lead the research effort over a 3-year...
This $3,150,000 Project Grant award from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) will fund a randomized clinical trial using noninvasive brain stimulation combined with written exposure therapy for post-traumatic stress disorder (PTSD) in military personnel with mild traumatic brain injury. The award was granted to The University of Texas Health Science Center at San Antonio, a Hispanic-serving academic medical institution with extensive...
This Project Grant award of $541,658.00 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports targeted auditory plasticity training to improve central hearing in mild traumatic brain injury (TBI). The primary awardee is The University of Texas at San Antonio (UTSA), a Hispanic-serving research university. UTSA will collaborate with Northeastern University on this project, which involves customizing an auditory...
The federal Project Grant award of $810,000.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research on "EARLY NEUROMODULATION FOR COGNITIVE RECOVERY AND REHABILITATION IN TRAUMATIC BRAIN INJURY" at the University of Cincinnati. The grant, awarded on Nov 1, 2024, with a completion date of Oct 31, 2027, will fund scientific investigations exploring innovative approaches to disease prevention, diagnosis, treatment,...
This federal Project Grant award of $1,247,189.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research interventions to address the mental health needs of warfighters with traumatic brain injury. The award, titled "TREATMENT INTERVENTIONS FOR THE MENTAL HEALTH NEEDS OF WARFIGHTERS WITH TRAUMATIC BRAIN INJURY (TIME)", was granted to General Dynamics Information Technology, Inc. (GDIT), a subsidiary of General Dynamics...
This three-year Project Grant from the Defense Health Agency, totaling $847,194, will support research on "BIOMARKERS OF HYPERACUSIS IN AUTISM SPECTRUM DISORDER" at the University of Texas at Dallas from September 2023 through September 2026. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research solutions for battlefield medicine and other health...
This $6,214,900 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program supports research on the role of genetic risk factors and immune response on neurovascular unit (NVU) function in post-traumatic brain injury (TBI) cognitive impairment. The primary awardee, the Scintillon Institute, a non-profit biomedical research organization in San Diego, California, will conduct this advanced scientific investigation over...
This federal Project Grant award in the amount of $747,507 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports an evaluation of an engineered calpain activity nanosensor in a mouse model of traumatic brain injury (TBI) at the University of California, San Diego (UCSD). The objective of the research is to advance the development of innovative technologies for monitoring and assessing traumatic brain injuries,...
The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $131,685 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "TARGETED AUDITORY PLASTICITY TRAINING TO IMPROVE CENTRAL HEARING IN MILD TBI", will support research to develop innovative approaches for improving central hearing in individuals with mild traumatic brain injury. The grant has a performance...
The Defense Health Agency awarded a $725,000 Project Grant to the University of Oklahoma Health Sciences Center to develop treatments for cognitive, motor, and sensory outcomes associated with mild traumatic brain injury and post-traumatic stress disorder. Funded through the Military Medical Research and Development program under the Cooperative Agreements and Other Transactions authority, this three-year award beginning April 15, 2023 will support research into modulating the NOP receptor...